XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 7 Months Ended 12 Months Ended
Jun. 30, 2022
Feb. 29, 2024
Jan. 31, 2024
Oct. 31, 2023
Sep. 30, 2023
Jul. 31, 2023
Jun. 30, 2022
Dec. 31, 2021
Nov. 30, 2021
May 31, 2021
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Jan. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2024
May 31, 2022
Mar. 31, 2022
Feb. 28, 2022
Jan. 31, 2022
Aug. 31, 2021
Jun. 30, 2020
Conversion fee, values   $ 35,000                                            
Warrants issued to purchase shares                     10,576,924   10,576,924                      
Warrants issuance cost                                 $ 2,900,000              
Purchase of warrants                     31,890,289   31,890,289                      
Common stock, par value                     $ 0.01   $ 0.01     $ 0.01                
Conversion fee, shares   500,000                                            
Debt instrument amount                         $ 1,052,675     $ 1,031,425                
Net accumulated losses                     $ (209,837) $ (6,757,000) (618,513) $ (7,282,419)                    
Working capital deficit                     16,000,000.0   16,000,000.0                      
Net cash used in operating activities                         500,000                      
Autotelic Inc [Member]                                                
Proceeds from related party debt                         400,000                      
Vyoung Trieu [Member]                                                
Proceeds from related party debt                         15,000                      
Oncotelic Warrant [Member]                                                
Warrants issued to purchase shares                                         33,000,000      
Purchase of common stock, value                                         $ 50,000      
Warrant [Member]                                                
Purchase of warrants                                   33,000,000            
Common Stock [Member]                                                
Conversion fee, values                         $ 35,000                      
Conversion fee, shares                         500,000                      
Biomedical Advanced Research and Development Authority [Member]                                                
Investment company, general partner advisory service                         $ 750,000                      
Supplemental Agreement [Member] | Golden Mountain Partners LLC [Member]                                                
Investment company, grant amount                         $ 1,200,000                      
JH Darbie Placement Agreement [Member]                                                
Debt conversion description                             Based on the placement agent agreement, JH Darbie was entitled to a non-refundable $25,000 fee to start the due diligence process and 2% due diligence fees and 13% commissions on all subsequent conversions or new funding. In addition, the Company provided warrant coverage equal to 13 % of all of the units sold to JH Darbie. As the Company converted an aggregate of 94 units, JH Darbie was entitled to earn a total of 3,055,000 warrants. A total of 5 unit holders under the PPM-1 opted not to participate in the PPM-2.                  
JH Darbie Placement Agreement [Member] | Warrant [Member]                                                
Common stock new share issued                             250,000                  
JH Darbie Placement Agreement [Member] | Accredited Investors [Member]                                                
Conversion fee, values       $ 1,050,000.00 $ 1,000,000.0 $ 1,000,000.0                                    
Debt conversion description         JH Darbie has the right to sell/convert a minimum of 10 Units and a maximum of 200 Units on a best-efforts basis JH Darbie has the right to sell/convert a minimum of 10 Units and a maximum of 200 Units on a best-efforts basis                                    
JH Darbie Placement Agreement [Member] | Additionally Accredited Investors [Member]                                                
Conversion fee, values     $ 300,000                                          
Equity Purchase Agreement [Member] | Peak One Opportunity Fund, L.P [Member]                                                
Common shares issued for cash                   $ 10,000,000.0                            
Common stock, par value                   $ 0.01                            
Note Purchase Agreements [Member] | Autotelic Inc [Member]                                                
Debt instrument face amount                                             $ 698,500  
Debt instrumental interest rate                                             5.00%  
Securities Purchase Agreements [Member]                                                
Common stock, par value               $ 0.01 $ 0.01                              
Debt instrument face amount               $ 250,000 $ 250,000                   $ 600,000 $ 250,000        
Proceeds from convertible debt               $ 1,250,000 $ 1,250,000                              
Common stock new share issued             4,025,000                                  
Securities Purchase Agreement [Member]                                                
Debt instrument face amount $ 340,000           $ 340,000                                  
Common stock new share issued                         7.6                      
Debt instrument amount $ 531,000                                              
Securities Purchase Agreement [Member] | Fourth Man LLC [Member]                                                
Convertible debt                               127,000                
Conversion fee, shares                         1,820,395                      
Securities Purchase Agreement and Purchase Agreement [Member] | Golden Mountain Partners [Member]                                                
Debt instrument face amount                                           $ 4,500,000   $ 4,500,000
Since Inception Date [Member]                                                
Net accumulated losses                               $ 34,000,000                
Point R merger agreement [Member]                                                
Working capital deficit                     $ 2,600,000   $ 2,600,000